Shares of Aurora Cannabis Inc. (TSE:ACB – Get Free Report) fell 0.7% on Friday . The stock traded as low as C$4.48 and last traded at C$4.57. 309,967 shares changed hands during mid-day trading, a decline of 24% from the average session volume of 406,930 shares. The stock had previously closed at C$4.60.
Wall Street Analyst Weigh In
Separately, Canaccord Genuity Group set a C$10.00 target price on shares of Aurora Cannabis and gave the company a “buy” rating in a research note on Tuesday, January 27th. Two research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Aurora Cannabis currently has a consensus rating of “Buy” and an average price target of C$9.25.
Read Our Latest Report on Aurora Cannabis
Aurora Cannabis Stock Performance
Aurora Cannabis (TSE:ACB – Get Free Report) last posted its earnings results on Wednesday, February 4th. The company reported C$0.03 earnings per share (EPS) for the quarter. The firm had revenue of C$94.19 million during the quarter. Aurora Cannabis had a negative net margin of 1.69% and a negative return on equity of 1.15%. On average, analysts expect that Aurora Cannabis Inc. will post -0.22 EPS for the current year.
About Aurora Cannabis
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.
See Also
- Five stocks we like better than Aurora Cannabis
- Samsung Joins the $1 Trillion Club as AI Memory Demand Explodes
- Japan’s Stealth Bull Market: How U.S. Investors Can Get Exposure
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
